Silexion Therapeutics Ltd... (SLXN)
NASDAQ: SLXN
· Real-Time Price · USD
7.39
0.03 (0.41%)
At close: Aug 15, 2025, 3:56 PM
7.24
-2.03%
After-hours: Aug 15, 2025, 07:47 PM EDT
Silexion Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Mar 31, 2021 |
Net Income | -1.74M | -1.75M | -11.86M | -1.49M | -1.42M | -1.68M | -809K | 162.95K | -774 | 494.41K | 292.58K | 42.69K | -245.66K | -241.77K | -97.75K |
Depreciation & Amortization | 4K | -12K | 22K | 7K | 8K | 6K | 10K | n/a | 15.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 21K | 31.97K | 5.8M | 32K | 32.00 | 34K | 32K | n/a | 32.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -621K | -1.08M | -947K | 263K | -430K | 422K | -155.16K | -176.5K | n/a | 155.49K | 71.53K | -64.2K | 200.29K | 57.75K | -713.21K |
Other Non-Cash Items | 81K | -251.97K | 3.82M | 83K | 167.97K | -47K | 82.16K | -418 | -184 | 10.39K | -9.56K | -36.35K | -95.19K | -189.45K | 5.78K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -824K | -947K | -430K | 302K | -505K | 430K | -156 | -176.5K | n/a | 155.49K | 71.53K | -64.2K | 200.29K | 57.75K | -713.21K |
Operating Cash Flow | -2.45M | -2.93M | -2.65M | -1.06M | -1.75M | -1.26M | -685K | -13.97K | -911 | 660.3K | 354.55K | -57.86K | -140.56K | -373.46K | -805.18K |
Capital Expenditures | -6K | n/a | -16K | n/a | -6K | -4K | -6K | n/a | n/a | 3.00 | -3 | -4 | n/a | 3.00 | 3.00 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 78K | n/a | 507.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -6K | n/a | -16K | n/a | -6K | -4K | 72K | n/a | 507.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 535K | n/a | 190K | 350K | 60K | 290K | 300K | -149.99K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 7.43M | -250K | 2.3M | n/a | n/a | n/a | n/a | n/a | -90.37M | n/a | n/a | n/a | n/a | n/a | -2.55M |
Financial Cash Flow | 7.43M | 2.18M | 2.92M | n/a | n/a | n/a | n/a | 535K | -90.37M | 190K | 350K | 60K | 290K | 300K | 116.1M |
Net Cash Flow | 4.96M | -753K | 276K | -1.08M | -1.81M | -1.17M | -679K | -36.97K | 7.92K | -142.62K | 184.53K | -161.2K | 140.06K | -75.64K | 294.99K |
Free Cash Flow | -2.46M | -2.93M | -2.67M | -1.06M | -1.76M | -1.26M | -691K | -13.97K | -911 | 660.3K | 354.55K | -57.86K | -140.56K | -373.46K | -805.18K |